![](/img/cover-not-exists.png)
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma
Evens, A. M., Carson, K. R., Kolesar, J., Nabhan, C., Helenowski, I., Islam, N., Jovanovic, B., Barr, P. M., Caimi, P. F., Gregory, S. A., Gordon, L. I.Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu179
Date:
July, 2014
File:
PDF, 30 KB
english, 2014